HICC: Humoral Immune Correlates for COVID19
HICC: Humoral Immune Correlates for COVID-19
Defining protective responses and critical readouts for clinical trials of vaccines and therapeutics
SARS-CoV-2 is an emerging virus with very high infectivity, responsible for the ongoing global pandemic of COVID-19. To maximise our success in protecting people against this disease, we work to understand and develop highly accurate tests to identify when a person has developed a protective immune response versus a COVID-19 disease response.
This is critical for guiding clinic and public health decisions and developing safe, effective vaccines.